Earnings Preview For Regenxbio
Portfolio Pulse from Benzinga Insights
Regenxbio (NASDAQ:RGNX) is set to release its quarterly earnings report on November 8, 2023. Analysts estimate an EPS of $-1.49. The company's past performance shows a trend of missing EPS estimates, which has led to drops in share price. The stock is currently trading at $15.79, down 21.22% over the last 52-week period.
November 07, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Regenxbio's upcoming earnings report could impact its stock price. Past misses on EPS estimates have led to share price drops. The stock is currently down 21.22% over the last 52-week period.
Regenxbio has a history of missing EPS estimates, which has negatively impacted its stock price. Given this trend and the current negative returns, it's likely that the upcoming earnings report could further depress the stock price, especially if the company misses estimates again.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100